Aquestive Therapeutics, Inc. — Director's Dealing 2019

Jan 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2019-01-02

Reporting Person: Slatko Gary H (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-01-02	Stock Option (Right to Purchase)	$7.18	A	75000	Acquired	2029-01-02	Common Stock (75000)	Direct

Footnotes

F1: The shares underlying the options vest in three annual installments of 25%, 25% and 50% on January 2, 2020, January 2, 2021 and January 2, 2022, respectively, subject in each case to Dr. Slatko's continuous service with the Issuer from the grant date through the applicable vesting date.